Taken together, these data suggest that the chemokine balance in tumors of HiAnx mice is shifted towards CCL22, which attracts regulatory/suppressor T cells that suppress anti-tumor immunity, and away from CTACK, which may attract protective anti-tumor T cells. Here, CCL22 is linked to neoplasm.